Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature

被引：15

作者：

Salinas, Carlos ^{[1
]}

Renner, Alex ^{[1
]}

Rojas, Carlos ^{[1
,2
]}

Samtani, Suraj ^{[1
]}

Burotto, Mauricio ^{[1
,2
]}

机构：

[1] Med Oncol Serv Bradford Hill, Santiago, Chile

[2] Clin Univ Andes, Med Oncol Serv, Las Condes, Chile

来源：

CASE REPORTS IN ONCOLOGY | 2020年 / 13卷 / 02期

关键词：

Ipilimumab; Nivolumab; Primary adrenal insufficiency; Immune-related adverse events; NIVOLUMAB PLUS IPILIMUMAB; OPEN-LABEL; MULTICENTER;

D O I：

10.1159/000507652

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management.

引用

页码：621 / 626

页数：6

共 50 条

[11] Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature
Cordes, Lisa M.
Davarpanah, Nicole N.
Reoma, Lauren B.
Gasmi, Billel
Quezado, Martha
Khan, Omar I.
Nath, Avindra
Apolo, Andrea B.
CLINICAL CASE REPORTS, 2020, 8 (01): : 24 - 32
[12] Immune checkpoint inhibitor therapy-associated encephalitis: a case series and review of the literature
Stuby, Johann
Herren, Thomas
Schwegler, Naumburger Guido
Papet, Claudia
Rudiger, Alain
SWISS MEDICAL WEEKLY, 2020, 150
[13] Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis
Thapi, Sahityasri
Leiter, Amanda
Galsky, Matthew
Gallagher, Emily J.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
[14] Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety and quality of life
Korde, Rasika
Veluswamy, Rajwanth
Allaire, Jason C.
Barnes, Gisoo
CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (08) : 1361 - 1368
[15] Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment
Hsu, Christine
Marshall, John L.
He, Aiwu Rum
ONCOLOGIST, 2020, 25 (02) : 105 - 111
[16] Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature
Li, Ling
Lou, Anqi
Yu, Junxian
ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (07) : 8460 - 8466
[17] A Rare Case of Immune-Mediated Primary Adrenal Insufficiency With Cytotoxic T-Lymphocyte Antigen-4 Inhibitor Ipilimumab in Metastatic Melanoma of Lung and Neck of Unknown Primary
Gaballa, Salem
Hlaing, Kyaw M.
Mahler, Nathan
Moursy, Safa
Ahmed, Ameenjamal
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
[18] Immune-Related Adverse Event-Related Adrenal Insufficiency Mediates Immune Checkpoint Inhibitors Efficacy in Cancer Treatment
Zhang, Shasha
Wu, Jianhua
Zhao, Yue
Zhang, Jingjing
Zhang, Xiaoyun
Wu, Chensi
Zhang, Zhidong
Guo, Zhanjun
CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 151 - 161
[19] Immune checkpoint inhibitor-associated new-onset primary adrenal insufficiency: a retrospective analysis using the FAERS
D. Lu
J. Yao
G. Yuan
Y. Gao
J. Zhang
X. Guo
Journal of Endocrinological Investigation, 2022, 45 : 2131 - 2137
[20] Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency
Manaka, Katsunori
Sato, Junichiro
Takeuchi, Maki
Watanabe, Kousuke
Kage, Hidenori
Kawai, Taketo
Sato, Yusuke
Miyagawa, Takuya
Yamada, Daisuke
Kume, Haruki
Sato, Shinichi
Nagase, Takahide
Iiri, Taroh
Nangaku, Masaomi
Makita, Noriko
SCIENTIFIC REPORTS, 2021, 11 (01)

← 1 2 3 4 5 →